Thyrocare Technologies has informed that the Board of Directors of the Company, at their meeting held yesterday, approved the Audited Financial Results (Stand-alone and Consolidated) for the Financial Year ended March 31, 2022 and have also decided to declare an interim dividend at the rate of Rs 15.00 per share (150% of the face value of Rs 10 each) for the financial year 2021-22. The Board has fixed, Thursday 12th May 2022 as the record date for the purpose of determining the entitlement of shareholders for the interim dividend.
The above information is a part of company’s filings submitted to BSE.
